Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.59 |
| ▸ | CALM1 | P0DP23 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CMA1 | P23946 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MIF | P14174 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29633110 | 1.00 | TAAR1 (1.00) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL857029 | 0.98 | TAAR1 (0.96) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| Hydrochloric Acid SCHEMBL29836913 | 0.98 | TAAR1 (0.96) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| Methane SCHEMBL11744005 | 0.98 | TAAR1 (0.96) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| Hypochlorous Acid SCHEMBL7493535 | 0.94 | TAAR1 (0.89) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| SCHEMBL29694229 | 0.89 | TAAR1 (0.79) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| SCHEMBL1813526 | 0.89 | TAAR1 (0.79) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| SCHEMBL1253622 | 0.88 | TAAR1 (0.79) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| SCHEMBL108087 | 0.87 | TAAR1 (0.77) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 | |
| SCHEMBL30928249 | 0.87 | TAAR1 (0.77) | TAAR1SLC6A4CALM1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 974 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118737523-B | Crosslinked polyethylene insulated medium-high voltage power cable and preparation method thereof | 无锡江南电缆有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-20250136548-A1 | FUNCTIONALIZED ALKYLAMINES | TERRAN BIOSCIENCES INC (US) | 2025-05-01 | — | — | US | claimed |
| CN-118126023-A | Pyrazole amide compound as well as preparation method and application thereof | 安徽中医药大学 | 2024-06-04 | — | — | CN | claimed |
| CN-117903660-A | Antibacterial clean type epoxy drinking water tank paint and preparation method thereof | 浙江鱼童新材料股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-117442609-A | Application of tetrahydrocarbazole derivative in preventing and treating cow mastitis pathogenic bacteria | 兰州大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117281120-A | Application of tetrahydrocarbazole derivative in preventing and controlling agricultural bacterial diseases | 兰州大学 | 2023-12-26 | — | — | CN | claimed |
| CN-114316951-B | Cadmium-based two-dimensional hybridization perovskite long afterglow material, and preparation method and application thereof | 南京邮电大学 | 2023-12-22 | — | — | CN | claimed |
| WO-2023141595-A2 | FUNCTIONALIZED ALKYLAMINES | TERRAN BIOSCIENCES, INC. (US) | 2023-07-27 | — | — | WO | claimed |
| CN-114057723-B | Synthesis method of 13-methyl berberine alkaloid | 四川大学 | 2023-05-26 | — | — | CN | claimed |
| CN-115093427-B | Medicine for treating Alzheimer disease and related diseases causing cognitive disorder | 哈尔滨医科大学 | 2023-03-24 | — | — | CN | claimed |
| WO-2007019251-A2 | SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2007-02-15 | — | — | WO | claimed |
| US-20070032531-A1 | SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2007-02-08 | — | — | US | claimed |
| JP-2007500717-A | — | — | 2007-01-18 | — | — | JP | claimed |
| WO-2007005763-A2 | COMBINATION OF A RENIN INHIBITOR AND AN INSULIN SECRETION ENHANCER OR AN INSULIN SENSITIZER | NOVARTIS AG (CH) | 2007-01-11 | — | — | WO | claimed |
| WO-2006138660-A2 | SPHINGOSINE KINASE INHIBITORS | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2006-12-28 | — | — | WO | claimed |
| US-20060287317-A1 | SPHINGOSINE KINASE INHIBITORS | APOGEE BIOTECHNOLOGY CORPORATION (US) | 2006-12-21 | — | — | US | claimed |
| WO-2006086445-A2 | COMBINATION THERAPY | XENON PHARMACEUTICALS INC. (CA) | 2006-08-17 | — | — | WO | claimed |
| EP-1648874-A2 | PIPERAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2006-04-26 | — | — | EP | claimed |
| US-20050065143-A1 | Pyridazine derivatives and their use as therapeutic agents | XENON PHARMACEUTICALS INC. (CA) | 2005-03-24 | — | — | US | claimed |
| WO-2005011655-A2 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | XENON PHARMACEUTICALS INC. (CA) | 2005-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065143-A1 | Pyridazine derivatives and their use as therapeutic agents | PRDX5, SNRPD3, SNRPD2 | TAAR1 2591/4885SLC6A4 4274/4885CALM1 3492/4885 |
| US-20060287317-A1 | SPHINGOSINE KINASE INHIBITORS | SPHK1, SPHK2, S1PR1 | TAAR1 2190/4885SLC6A4 3019/4885CALM1 2764/4885 |
| US-20070032531-A1 | SPHINGOSINE KINASE INHIBITORS AND METHODS OF THEIR USE | SPHK1, SPHK2, S1PR2 | TAAR1 4180/4885SLC6A4 4337/4885CALM1 2638/4885 |
| US-20250136548-A1 | FUNCTIONALIZED ALKYLAMINES | BDNF, HTR2A, NTRK2 | TAAR1 146/4885SLC6A4 111/4885CALM1 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.